NO983691D0 - Forbindelser tilhörende amidiniumfamilien, farmasöytiske preparater inneholdende disse samt anvendelse derav - Google Patents

Forbindelser tilhörende amidiniumfamilien, farmasöytiske preparater inneholdende disse samt anvendelse derav

Info

Publication number
NO983691D0
NO983691D0 NO983691A NO983691A NO983691D0 NO 983691 D0 NO983691 D0 NO 983691D0 NO 983691 A NO983691 A NO 983691A NO 983691 A NO983691 A NO 983691A NO 983691 D0 NO983691 D0 NO 983691D0
Authority
NO
Norway
Prior art keywords
amidinium
family
compounds
pharmaceutical compositions
compositions containing
Prior art date
Application number
NO983691A
Other languages
English (en)
Other versions
NO983691L (no
NO311806B1 (no
Inventor
Jean-Marie Lehn
Original Assignee
Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26232562&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO983691(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from FR9602604A external-priority patent/FR2745569B1/fr
Priority claimed from FR9609557A external-priority patent/FR2751972B1/fr
Application filed by Rech Scient filed Critical Rech Scient
Publication of NO983691L publication Critical patent/NO983691L/no
Publication of NO983691D0 publication Critical patent/NO983691D0/no
Publication of NO311806B1 publication Critical patent/NO311806B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO19983691A 1996-03-01 1998-08-12 Forbindelser tilhörende amidiniumfamilien, farmasöytiske preparater inneholdende disse samt anvendelse derav NO311806B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9602604A FR2745569B1 (fr) 1996-03-01 1996-03-01 Composes apparentes a la famille des amidiniums, compositions pharmaceutiques les contenant et leurs applications
FR9609557A FR2751972B1 (fr) 1996-07-30 1996-07-30 Composes apparentes a la famille des amidiniums, compositions pharmaceutiques les contenant et leurs applications
PCT/FR1997/000364 WO1997031935A1 (fr) 1996-03-01 1997-02-28 Composes apparentes a la famille des amidiniums, compositions pharmaceutiques les contenant et leurs applications

Publications (3)

Publication Number Publication Date
NO983691L NO983691L (no) 1998-08-12
NO983691D0 true NO983691D0 (no) 1998-08-12
NO311806B1 NO311806B1 (no) 2002-01-28

Family

ID=26232562

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19983691A NO311806B1 (no) 1996-03-01 1998-08-12 Forbindelser tilhörende amidiniumfamilien, farmasöytiske preparater inneholdende disse samt anvendelse derav

Country Status (18)

Country Link
US (2) US6143729A (no)
EP (1) EP0888379B1 (no)
JP (1) JP4271260B2 (no)
KR (1) KR19990087372A (no)
AT (1) ATE198599T1 (no)
AU (1) AU723998B2 (no)
BR (1) BRPI9707889B8 (no)
CZ (1) CZ295225B6 (no)
DE (1) DE69703878T2 (no)
DK (1) DK0888379T3 (no)
ES (1) ES2154453T3 (no)
GR (1) GR3035205T3 (no)
HU (1) HU228072B1 (no)
IL (1) IL125926A (no)
NO (1) NO311806B1 (no)
PT (1) PT888379E (no)
SK (1) SK283575B6 (no)
WO (1) WO1997031935A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6884430B1 (en) 1997-02-10 2005-04-26 Aventis Pharma S.A. Formulation of stabilized cationic transfection agent(s) /nucleic acid particles
FR2763943B1 (fr) * 1997-05-28 1999-07-09 Rhone Poulenc Rorer Sa Composes, leur preparation et leur utilisation pour le transfert d'acides nucleiques dans les cellules
FR2777017B1 (fr) * 1998-04-02 2002-08-23 Rhone Poulenc Rorer Sa Nouveaux agents de transfert d'acides nucleiques, compositions les contenant et leurs applications
EP1068188A1 (fr) * 1998-04-02 2001-01-17 Aventis Pharma S.A. Nouveaux agents de transfert d'acides nucleiques, compositions les contenant et leurs applications
DE10109898A1 (de) * 2001-02-21 2002-09-05 Novosom Gmbh Lipide mit veränderlicher Ladung
AU2002257904B2 (en) * 2001-05-14 2007-12-06 Gencell S.A. Polythiourea lipid derivatives
FR2824557B1 (fr) * 2001-05-14 2003-08-29 Aventis Pharma Sa Derives lipidiques de polythiouree
FR2829136B1 (fr) 2001-08-29 2006-11-17 Aventis Pharma Sa Derives lipidiques d'aminoglycosides
US7472563B2 (en) 2002-01-17 2009-01-06 Alfa Laval Corporate Ab Submerged evaporator with integrated heat exchanger
WO2006118283A1 (ja) * 2005-04-28 2006-11-09 Nippon Soda Co., Ltd. 新規なグアニジン化合物、製造方法及びそれらを含有する殺菌性組成物
CA2665403C (en) * 2006-10-04 2015-06-23 Institut National De La Sante Et De La Recherche Medicale (Inserm) Compositions comprising a sirna and lipidic 4,5-disubstituted 2-deoxystreptamine ring aminoglycoside derivatives and uses thereof
JP2012509258A (ja) * 2008-11-17 2012-04-19 エンゾン ファーマシューティカルズ，インコーポレーテッド 核酸送達系のための分岐カチオン性脂質

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283185A (en) * 1991-08-28 1994-02-01 University Of Tennessee Research Corporation Method for delivering nucleic acids into cells
AU691226B2 (en) * 1993-11-24 1998-05-14 Megabios Corporation Amphiphilic derivatives of guanidine
US5777153A (en) * 1994-07-08 1998-07-07 Gilead Sciences, Inc. Cationic lipids
US6071890A (en) * 1994-12-09 2000-06-06 Genzyme Corporation Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy
US5811406A (en) * 1995-06-07 1998-09-22 Regents Of The University Of California Dry powder formulations of polynucleotide complexes

Also Published As

Publication number Publication date
NO983691L (no) 1998-08-12
ATE198599T1 (de) 2001-01-15
US6143729A (en) 2000-11-07
WO1997031935A1 (fr) 1997-09-04
EP0888379B1 (fr) 2001-01-10
BRPI9707889B8 (pt) 2016-11-08
CZ295225B6 (cs) 2005-06-15
KR100452062B1 (no) 2005-04-08
KR19990087372A (ko) 1999-12-27
IL125926A0 (en) 1999-04-11
AU1930497A (en) 1997-09-16
NO311806B1 (no) 2002-01-28
US6316422B1 (en) 2001-11-13
SK283575B6 (sk) 2003-09-11
HU228072B1 (en) 2012-09-28
HUP9902465A3 (en) 2009-10-28
DE69703878D1 (de) 2001-02-15
BR9707889B1 (pt) 2010-03-23
GR3035205T3 (en) 2001-04-30
IL125926A (en) 2004-09-27
DE69703878T2 (de) 2001-04-26
BR9707889A (pt) 2000-01-04
ES2154453T3 (es) 2001-04-01
CZ277298A3 (cs) 1998-12-16
HUP9902465A1 (hu) 1999-12-28
SK118298A3 (en) 1999-02-11
PT888379E (pt) 2001-05-31
JP2000506136A (ja) 2000-05-23
DK0888379T3 (da) 2001-01-29
AU723998B2 (en) 2000-09-07
EP0888379A1 (fr) 1999-01-07
JP4271260B2 (ja) 2009-06-03

Similar Documents

Publication Publication Date Title
NL350077I1 (nl) Cyprosulfamide
DE69729583D1 (de) N-(amidinophenyl)-n'-(subst.)-3h-2,4-benzodiazepin-3-on derivative als faktor xa inhibitoren
YU11997A (sh) Laktamski derivati i njihove farmaceutske kompozicije
DE69420564D1 (de) Immunsuppressive und antiallergische verbindungen; z.b. n-(3-oxohexanoyl)-homoserinlacton
NO971415D0 (no) Aminoheterocykliske derivater som anti-trombose- eller antikoagulantmidler
DK41193D0 (da) Ionkanalaabnere
FI19992555A (fi) Antibakteerisia oksatosolidinoniaineita, joilla on tiokarbonyylifunktionaalisuus
TR199701427T1 (xx) �nsektisidler olarak kullan�lan bisiklik aminler.
ATE201674T1 (de) Heterozyclische fungizide
DE69127690D1 (de) Antiatherosklerotische und antithrombotische 1-benzopyran-4-on- und 2-amino-1,3-benzoxazin-4-on-derivate
TR199701654T1 (xx) 4-Fenilaminotiyazol t�revleri.
NO983691D0 (no) Forbindelser tilhörende amidiniumfamilien, farmasöytiske preparater inneholdende disse samt anvendelse derav
IT1285770B1 (it) Composti corticoidei
IL140070A0 (en) Benzamide derivatives and pharmaceutical compositions containing the same
NO981393D0 (no) Guanidinoproteasehemmere
TR199701298T1 (xx) Tetralinler.
DE69017627D1 (de) Isochinolinderivate und ihre Salze als Proteasehemmer.
RO116856B1 (ro) Compoziţie erbicidă, lichidă, pe bază de n-(fosfonometil)glicină
DK0777471T3 (da) Inhibering af leukotrienbiosynese med urinstofderivater
MX9603273A (es) Tetrahidropirimidinas artropodicidas.
IT1253878B (it) Derivati mono-, bi- o tricarbociclici di acidi fosfinici o fosfonici
TH8579EX (th) อนุพันธ์ของไกลซีน
TH8579A (th) อนุพันธ์ของไกลซีน
TH19545A (th) อนุพันธ์เพปไทด์
IT1271430B (it) Derivati di indenopiridazioni e benzocinnolinoni ad attivita' antitumorale

Legal Events

Date Code Title Description
MK1K Patent expired